Logo image
Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication
Journal article   Open access   Peer reviewed

Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication

Jinhua Xiang, James H McLinden, Thomas M Kaufman, Emma L Mohr, Nirjal Bhattarai, Qing Chang and Jack T Stapleton
Virology (New York, N.Y.), Vol.430(1), pp.53-62
08/15/2012
DOI: 10.1016/j.virol.2012.04.019
PMCID: PMC3568392
PMID: 22608061
url
https://doi.org/10.1016/j.virol.2012.04.019View
Published (Version of record) Open Access

Abstract

GB virus C (GBV-C) infection is associated with prolonged survival in HIV-infected cohorts, and GBV-C E2 protein inhibits HIV entry when added to CD4+ T cells. To further characterize E2 effects on HIV replication, stably transfected Jurkat cell lines expressing GBV-C E2 or control sequences were infected with HIV and replication was measured. HIV replication (all 6 isolates studied) was inhibited in all cell lines expressing a region of 17 amino acids of GBV-C E2, but not in cell lines expressing E2 without this region. In contrast, mumps and yellow fever virus replication was not inhibited by E2 protein expression. Synthetic GBV-C E2 17mer peptides did not inhibit HIV replication unless they were fused to a tat-protein-transduction-domain (TAT) for cellular uptake. These data identify the region of GBV-C E2 protein involved in HIV inhibition, and suggest that this GBV-C E2 peptide must gain entry into the cell to inhibit HIV. ► GBV-C E2 expression in a CD4+ T cell line inhibits HIV entry. ► Expression of 17 amino acids of GBV-C E2 protein inhibits HIV in a CD4+ T cell line. ► Cells expressing E2 inhibit HIV in bystander cells if there is cell-to-cell contact. ► Intracellular, but not extracellular E2 peptide inhibits HIV if it gains entry.
HIV GBV-C Envelope glycoprotein

Details

Metrics

Logo image